The anti-inflammatory drugs market comprises prescription and over-the-counter drugs that provide relief from pain and inflammatory symptoms. These drugs are used to treat various inflammatory conditions such as arthritis, bursitis, tendinitis, gout, and muscle strains. Anti-inflammatory drugs work by reducing hormones that cause inflammation and swelling. The global rise in the prevalence of arthritis, cardiovascular diseases, and other inflammatory ailments has boosted the demand for anti-inflammatory medications over the years. The global anti-inflammatory drugs market is estimated to be valued at US$ 118.21 billion in 2024 and is expected to exhibit a CAGR of 5.5% over the forecast period of 2024 to 2031.
Key Takeaways
Key players operating in the Anti-Inflammatory Drugs Market Demand are 48 London, Alpine Escape, Arburton Ltd, Aspen Luxury Concierge Service LLC, AZ Luxe, Bon Vivant, Globe Infinite, Ibiza Luxury Concierge Service, Innerplace Co., and John Paul. These players are focusing on new product launches and geographical expansions to strengthen their market presence.
In terms of opportunities, the rising geriatric population suffering from chronic inflammatory disorders, growing awareness about inflammatory drugs, and increasing R&D investments present lucrative prospects for market players. The global market is also expected to gain momentum owing to the expansion of healthcare infrastructure in developing regions.
Moreover, owing to increasing penetration in emerging nations and growing cross-border collaborations, anti-inflammatory drug makers are exploring expansion opportunities in Asia Pacific, Latin America, the Middle East & Africa, and Eastern European countries.
Market Drivers
One of the key drivers for the Anti-Inflammatory Drugs Market is the increasing global incidence of arthritis. As per estimates, over 350 million people suffer from arthritis worldwide, and India alone has over 100 million cases. The rising elderly population, sedentary lifestyles, and growing obesity rates have contributed to an upsurge in arthritis patients requiring anti-inflammatory therapy.
Market Restrain
Stringent regulations associated with the approval and commercialization of novel anti-inflammatory drugs pose a major challenge for drug makers. Further, after the expiry of patents, manufacturers face intense competition from generic formulations, impacting their revenues.
Segment Analysis
Nonsteroidal anti-inflammatory drugs (NSAIDs) sub segment dominates the anti-inflammatory drugs market. NSAIDs are the most frequently prescribed therapeutic class of medication. They help reduce pain, swelling and fever by blocking the production of prostaglandins - hormone-like substances in the body that promote inflammation. NSAIDs such as ibuprofen, naproxen and diclofenac account for over 50% of the anti-inflammatory drugs market share due to their high prescription rates and over-the-counter availability for mild to moderate pain relief.
Global Analysis
The North American region dominates the global anti-inflammatory drugs market, with the United States being the major revenue generating country. Rising prevalence of arthritis and other inflammatory conditions coupled with high healthcare spending in the US drives the North American anti-inflammatory drugs market. Asia Pacific is projected to witness the highest growth during the forecast period due to growing geriatric population, increasing disposable income and higher healthcare investments in emerging economies like China and India.
Get more insights on Anti-Inflammatory Drugs Market
Also read related article on Bioreactors Market
Comments
0 comment